2012 InterLymph Report


The InterLymph Consortium, or formally the International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies, is an open scientific forum for epidemiologic research in lymphomas. Formed in 2001, the consortium is a group of international investigators who have completed or have ongoing case-control studies and who discuss and undertake research projects that pool data across studies or undertake collaborative research.

The InterLymph Consortium with its five working groups conducts annual meetings to discuss, collaborate and develop ongoing and future research projects.

The 2012 Annual Scientific Meeting was held from 7-9th June in Bethesda, Maryland, USA at the National Institutes of Health. Seventy-nine delegates from North America, Canada, Europe, Israel and Australia met to discuss ongoing pooled analyses, review provisional results, and plan new initiatives. Lymphoma is a heterogeneous group of haematological malignancies. International pooled analyses of data from several thousands of people with and without lymphoma are required to study factors associated with individual lymphoma subtypes.

The Consortium is currently undertaking several large-scale and internationally unique initiatives. The subtypes initiative includes data on more than 20,000 individuals and will report on the environmental, occupational, and lifestyle factors associated with 11 non-Hodgkin lymphoma subtypes, including the more common subtypes such as diffuse large B-cell lymphoma and follicular lymphoma, and rarer subtypes such as mantel cell lymphoma and acute lymphocytic lymphoma. The results are expected in 2013.

The InterLymph Genome Wide Association Study includes several thousand participants from a number of case-control and cohort studies. Cutting-edge data on the genetic risk factors for a number of subtypes is expected to be reported in the near future.

Other Consortium projects that will be completed within the next 12 months include studies of the relationship between non-Hodgkin lymphoma risk and occupation, diet, and blood transfusions, as well as a number of projects exploring the interaction between environmental factors and genetic predisposition.

A new Consortium working group, Lymphoid Cancer Families, has been established. This initiative is seeking to identify families with two or more affected members with Hodgkin lymphoma, non-Hodgkin lymphoma, lymphoid leukemia, or multiple myeloma. There is great interest in exploring genetic differences and similarities in these families and interested family members and researchers can contact Angie Brooks-Wilson (This email address is being protected from spambots. You need JavaScript enabled to view it.‎) for more information.

For further information or to book an interview with a researcher, please contact:

Karen Van Rassel

Lymphoma Coalition

This email address is being protected from spambots. You need JavaScript enabled to view it.

Aaron Norman


This email address is being protected from spambots. You need JavaScript enabled to view it.



Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 02/19/19. Copyright © 2018 Lymphoma Coalition. All rights reserved.